Report Highlights
The global syringes market should reach $26.3 billion by 2026 from $17.9 billion in 2021 at a compound annual growth rate (CAGR) of 7.9% for the forecast period of 2021 to 2026.
Report Includes
- 29 data tables and 18 additional tables
- A brief general outlook of the global market for syringes within the medical device industry
- Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Estimation of current market size and revenue sales forecast for global syringes market, and corresponding market share analysis by syringes type, material, usability and geography
- Highlights of emerging technology trends, opportunities and deterrents in the market estimating current and future demand for syringes; and identification of the companies that are best positioned to meet this demand
- Discussion of key market dynamics, clinical applications, industry structure, regulatory scenario, and penetration of technologies within the Medtech industry
- Assessment of the impact of COVID-19 crisis on the MedTech industry as against its economic burden on the global economy
- Porter’s Five Forces analysis of the syringes market considering both the micro and macro environmental factors prevailing in the market
- Competitive landscape of the major players in the global syringes market, their competitive benchmarking and major growth strategies within the global market
- Descriptive company profiles of the leading industry players, including Becton, Dickinson and Company, Cardinal Health Inc., Hindustan Syringes & Medical Devices Ltd., Nipro Corp. and Smiths Medical
Report Scope
This report offers a detailed picture of the market for syringes, highlighting the current and future market potential for syringes and providing a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. This report also covers market projections through 2026 and key market players.
This report details market shares for syringes based on type, usability, material and geography. Based on type, the market is segmented into general syringes, specialized syringes and smart syringes. Based on usability, the market is segmented into disposable syringes and sterilizable/reusable syringe. Based on material, the market is segmented into plastic syringes and glass syringes.
Based on geography, the market has been segmented into North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the UK, France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021-2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.s
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
Related Reports
Prefilled Syringes: Global Markets
The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.
Autoinjectors: Global Markets
The global market for autoinjectors should grow from $41.5 billion in 2021 to $85.2 billion by 2026, at compound annual growth rate (CAGR) of 15.5% for the period of 2021-2026.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate (CAGR) of 9.3% from 2018 to 2023.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More